SCHEMBL25462014

SCHEMBL25462014

c1ccc2c(c1)sc1cc(-c3cc4ccncc4cn3)ncc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 2/20 0.39
GPR3 P46089 1/20 0.39
MAPT P10636 3/20 0.37
RAB9A P51151 3/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CLK1 P49759 2/20 0.37
KDM4E B2RXH2 2/20 0.35
POLB P06746 1/20 0.35
HTT P42858 1/20 0.35
RAD52 P43351 1/20 0.35
GABRA1 P14867 2/20 0.34
MIF P14174 1/20 0.34
TDO2 P48775 1/20 0.34
CSNK1D P48730 1/20 0.33
CSNK1E P49674 1/20 0.33
DYRK1A Q13627 1/20 0.33
NPC1 O15118 2/20 0.33
HASPIN Q8TF76 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25462015 0.94 GRM4 (0.44) GRM4GPR3MAPTRAB9AALDH1A1
SCHEMBL25461977 0.89 GABRA1 (0.40) GRM4GPR3MAPTRAB9AALDH1A1
SCHEMBL25461711 0.87 GPR3 (0.45) GRM4GPR3MAPTRAB9AALDH1A1
SCHEMBL25461885 0.86 NPC1 (0.40) GRM4MAPTRAB9AKDM4EPOLB
SCHEMBL25461852 0.84 NPC1 (0.39) GRM4MAPTRAB9AALDH1A1KDM4E
SCHEMBL25461975 0.83 GRM4 (0.44) GRM4GPR3MAPTRAB9AALDH1A1
SCHEMBL25462008 0.83 MAPT (0.38) GRM4GPR3MAPTRAB9AALDH1A1
SCHEMBL25462001 0.83 GPR3 (0.36) GRM4GPR3MAPTRAB9AALDH1A1
SCHEMBL25462000 0.83 MAP4K4 (0.42) GRM4GPR3MAPTRAB9AALDH1A1
SCHEMBL25462010 0.81 GPR3 (0.37) GRM4GPR3MAPTRAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE OCIAD1, OCIAD2, EHD1 GRM4 4220/4885GPR3 4426/4885MAPT 2164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.